The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance

R. Bracale, G. Labruna, C. Finelli, A. Daniele, L. Sacchetti, G. Oriani, F. Contaldo, F. Pasanisi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background and aims: The insulin resistance (IR) is a major metabolic impairment in severe obesity, a multifactorial disease in which the importance of the effect of single nucleotide polymorphisms (SNP) associations in different rather than individual genes was established. The aim of this study was to test the predictive value of presence/absence of polymorphisms/variants in β3-adrenergic receptor (ADRB3), uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor γ(PPARγ), and adiponectin (ADIPOQ) genes in diagnosing the IR in obesity. Subjects and methods: We studied 112 (40 males, 72 females) severely obese (body mass index: 48.5±7.5 kg/m 2) subjects recruited from the outpatient obesity clinic of Federico II University Hospital in Naples. Genomic DNA was extracted from peripheral leukocytes with a commercial kit. The gene polymorphisms Trp64Arg in ADRB3, -3826 A>G in UCP1, Pro12Ala in PPARγ, and c.268G>A, c.331T>C, and c.334C>T in ADIPOQ were characterized by TaqMan assay or by direct sequencing (ADIPOQ). Results and conclusion: Our results demonstrate that -3826A>G UCP1 polymorphism is associated with IR in morbid obesity. Further, the lack of any polymorphisms, Trp64Arg in ADRB3 and/or -3826 A>G in UCP1 and/or Pro12Ala in PPARγ and/or c.268G>A, c.331T>C and c.334C>T in ADIPOQ, appears a useful prognostic factor (NPV=100%) toward the IR onset in these obese patients representing a further parameter for an earlier and appropriate therapy.

Original languageEnglish
Pages (from-to)2-4
Number of pages3
JournalJournal of Endocrinological Investigation
Volume35
Issue number1
Publication statusPublished - Jan 2012

Fingerprint

Peroxisome Proliferator-Activated Receptors
Insulin Resistance
Morbid Obesity
Genes
Obesity
Predictive Value of Tests
Adiponectin
Secondary Prevention
Ambulatory Care Facilities
Adrenergic Receptors
Single Nucleotide Polymorphism
Body Mass Index
Leukocytes
Uncoupling Protein 1
DNA

Keywords

  • ADIPOQ
  • ADRB3
  • Insulin resistance
  • PPARγ
  • Severe obesity
  • UCP1

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance. / Bracale, R.; Labruna, G.; Finelli, C.; Daniele, A.; Sacchetti, L.; Oriani, G.; Contaldo, F.; Pasanisi, F.

In: Journal of Endocrinological Investigation, Vol. 35, No. 1, 01.2012, p. 2-4.

Research output: Contribution to journalArticle

Bracale, R, Labruna, G, Finelli, C, Daniele, A, Sacchetti, L, Oriani, G, Contaldo, F & Pasanisi, F 2012, 'The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance', Journal of Endocrinological Investigation, vol. 35, no. 1, pp. 2-4.
Bracale, R. ; Labruna, G. ; Finelli, C. ; Daniele, A. ; Sacchetti, L. ; Oriani, G. ; Contaldo, F. ; Pasanisi, F. / The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance. In: Journal of Endocrinological Investigation. 2012 ; Vol. 35, No. 1. pp. 2-4.
@article{9645e5fc578d4174ade37eaa444bfcd6,
title = "The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance",
abstract = "Background and aims: The insulin resistance (IR) is a major metabolic impairment in severe obesity, a multifactorial disease in which the importance of the effect of single nucleotide polymorphisms (SNP) associations in different rather than individual genes was established. The aim of this study was to test the predictive value of presence/absence of polymorphisms/variants in β3-adrenergic receptor (ADRB3), uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor γ(PPARγ), and adiponectin (ADIPOQ) genes in diagnosing the IR in obesity. Subjects and methods: We studied 112 (40 males, 72 females) severely obese (body mass index: 48.5±7.5 kg/m 2) subjects recruited from the outpatient obesity clinic of Federico II University Hospital in Naples. Genomic DNA was extracted from peripheral leukocytes with a commercial kit. The gene polymorphisms Trp64Arg in ADRB3, -3826 A>G in UCP1, Pro12Ala in PPARγ, and c.268G>A, c.331T>C, and c.334C>T in ADIPOQ were characterized by TaqMan assay or by direct sequencing (ADIPOQ). Results and conclusion: Our results demonstrate that -3826A>G UCP1 polymorphism is associated with IR in morbid obesity. Further, the lack of any polymorphisms, Trp64Arg in ADRB3 and/or -3826 A>G in UCP1 and/or Pro12Ala in PPARγ and/or c.268G>A, c.331T>C and c.334C>T in ADIPOQ, appears a useful prognostic factor (NPV=100{\%}) toward the IR onset in these obese patients representing a further parameter for an earlier and appropriate therapy.",
keywords = "ADIPOQ, ADRB3, Insulin resistance, PPARγ, Severe obesity, UCP1",
author = "R. Bracale and G. Labruna and C. Finelli and A. Daniele and L. Sacchetti and G. Oriani and F. Contaldo and F. Pasanisi",
year = "2012",
month = "1",
language = "English",
volume = "35",
pages = "2--4",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "1",

}

TY - JOUR

T1 - The absence of polymorphisms in ADRB3, UCP1, PPARγ, and ADIPOQ genes protects morbid obese patients toward insulin resistance

AU - Bracale, R.

AU - Labruna, G.

AU - Finelli, C.

AU - Daniele, A.

AU - Sacchetti, L.

AU - Oriani, G.

AU - Contaldo, F.

AU - Pasanisi, F.

PY - 2012/1

Y1 - 2012/1

N2 - Background and aims: The insulin resistance (IR) is a major metabolic impairment in severe obesity, a multifactorial disease in which the importance of the effect of single nucleotide polymorphisms (SNP) associations in different rather than individual genes was established. The aim of this study was to test the predictive value of presence/absence of polymorphisms/variants in β3-adrenergic receptor (ADRB3), uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor γ(PPARγ), and adiponectin (ADIPOQ) genes in diagnosing the IR in obesity. Subjects and methods: We studied 112 (40 males, 72 females) severely obese (body mass index: 48.5±7.5 kg/m 2) subjects recruited from the outpatient obesity clinic of Federico II University Hospital in Naples. Genomic DNA was extracted from peripheral leukocytes with a commercial kit. The gene polymorphisms Trp64Arg in ADRB3, -3826 A>G in UCP1, Pro12Ala in PPARγ, and c.268G>A, c.331T>C, and c.334C>T in ADIPOQ were characterized by TaqMan assay or by direct sequencing (ADIPOQ). Results and conclusion: Our results demonstrate that -3826A>G UCP1 polymorphism is associated with IR in morbid obesity. Further, the lack of any polymorphisms, Trp64Arg in ADRB3 and/or -3826 A>G in UCP1 and/or Pro12Ala in PPARγ and/or c.268G>A, c.331T>C and c.334C>T in ADIPOQ, appears a useful prognostic factor (NPV=100%) toward the IR onset in these obese patients representing a further parameter for an earlier and appropriate therapy.

AB - Background and aims: The insulin resistance (IR) is a major metabolic impairment in severe obesity, a multifactorial disease in which the importance of the effect of single nucleotide polymorphisms (SNP) associations in different rather than individual genes was established. The aim of this study was to test the predictive value of presence/absence of polymorphisms/variants in β3-adrenergic receptor (ADRB3), uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor γ(PPARγ), and adiponectin (ADIPOQ) genes in diagnosing the IR in obesity. Subjects and methods: We studied 112 (40 males, 72 females) severely obese (body mass index: 48.5±7.5 kg/m 2) subjects recruited from the outpatient obesity clinic of Federico II University Hospital in Naples. Genomic DNA was extracted from peripheral leukocytes with a commercial kit. The gene polymorphisms Trp64Arg in ADRB3, -3826 A>G in UCP1, Pro12Ala in PPARγ, and c.268G>A, c.331T>C, and c.334C>T in ADIPOQ were characterized by TaqMan assay or by direct sequencing (ADIPOQ). Results and conclusion: Our results demonstrate that -3826A>G UCP1 polymorphism is associated with IR in morbid obesity. Further, the lack of any polymorphisms, Trp64Arg in ADRB3 and/or -3826 A>G in UCP1 and/or Pro12Ala in PPARγ and/or c.268G>A, c.331T>C and c.334C>T in ADIPOQ, appears a useful prognostic factor (NPV=100%) toward the IR onset in these obese patients representing a further parameter for an earlier and appropriate therapy.

KW - ADIPOQ

KW - ADRB3

KW - Insulin resistance

KW - PPARγ

KW - Severe obesity

KW - UCP1

UR - http://www.scopus.com/inward/record.url?scp=84861970088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861970088&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 2

EP - 4

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 1

ER -